Impax Laboratories On The Forbes America S Best Small Companies List Impax laboratories, inc. is a technology based, specialty pharmaceutical company. the company is focused on the development and commercialization of bioequivalent and brand name pharmaceuticals. The russell 2000 index tracking small companies is down 2.8% this year, compared with a 13.8% gain for the s&p 500, and small caps remain 30% lower than their 2021 peak.
Impax Laboratories Inc 2017 Q2 Results Earnings Call Slides Impax laboratories is now part of. amneal pharmaceuticals. on may 4, 2018, amneal pharmaceuticals and impax laboratories combined under one corporate parent, and now operate as amneal pharmaceuticals. amneal pharmaceuticals, inc. is a publicly listed company. traded on the new york stock exchange (nyse: amrx). visit amneal . The move will hand impax shareholders 25% of the new company—which will take amneal’s name and have an expected value of $6.4 billion, the wall street journal says—while amneal’s owners. 2019 revenue: $60 million. staff size: 90. started by ally and jeff davidson in 2008, camp gladiator runs a network of 1,000 personal trainers that host hour long full body workout sessions for. Impax laboratories, inc. is a specialty pharmaceutical company focused on developing, manufacturing and marketing generic and branded products. impax generics includes the company’s legacy global pharmaceuticals business as well as the acquired corepharma and lineage therapeutics businesses.
Comments are closed.